CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 4 Grant or award Chief Business & Legal Officer acquired 181,818 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 216,897 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Development Officer acquired 62,030 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award President, CEO and Chairman acquired 90,804 shares (grant or award)
- 8-K Event Bylaws or fiscal year change
- 424B4 Offering Prospectus
- FWP Offering Free Writing Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 13 · 248 filings